{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:24:14Z","timestamp":1753892654607,"version":"3.41.2"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:p>A number of case studies describing hypnotherapy in the treatment of anxiety disorder patients have already been published. Only a few randomized controlled trials (RCTs) investigated the efficacy of hypnotherapy but focused mainly on symptoms rather than specific mental disorders. The goal of this study was to investigate whether hypnotherapy (HT) was superior to a waitlist control group (WL) in the reduction of agoraphobia-related symptoms. Further goals were to report the feasibility of hypnotherapy as well as attrition and completion rates and detect (epi-)genetic variables, which might play a role in treatment outcome. This pilot study was based on a monocentric two-armed randomized controlled rater-blind clinical trial that was conducted between 2018 and 2020 with a waitlist control group. A total of 36 patients diagnosed with agoraphobia were randomized to either HT or WL. Patients in HT received individual outpatient treatment with hypnotherapy with 8 to 12 sessions for a period of 3 months. Patients in WL received HT after 3 months. Agoraphobia-related symptoms were assessed at baseline, after the treatment, and 3 months later in both groups with a clinician rating. The primary hypothesis concerning the difference between groups in the individual percentage symptom reduction could be confirmed in the intention-to-treat, not the per-protocol sample. Additionally, we applied repeated-measures analyses of variance and found a higher symptom decrease in HT compared with WL patients in three of the five imputed datasets. The dropout rate was low, and satisfaction with the treatment was high. HT patients experienced a strong symptom reduction after receiving hypnotherapy. WL patients improved slightly during the waiting period. The <jats:italic>COMT<\/jats:italic> Val<jats:sup>108\/158<\/jats:sup>Met genotype had an effect on the agoraphobia-related symptoms as well as on <jats:italic>COMT<\/jats:italic> DNA methylation levels. This is the first study to indicate that hypnotherapy performed better than a waitlist control group regarding the reduction in anxiety symptoms in an RCT. Future studies should confirm the efficacy of hypnotherapy and compare the treatment with a standard treatment for anxiety disorders in a larger trial. Future studies should also investigate whether hypnotic susceptibility is associated with <jats:italic>COMT<\/jats:italic> Val<jats:sup>108\/158<\/jats:sup>Met genotype and could predict treatment success for HT.<\/jats:p><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03684577<\/jats:ext-link>, identifier: NCT03684577.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyg.2023.1213792","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T15:54:45Z","timestamp":1691682885000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Hypnotherapy for agoraphobia\u2014Feasibility and efficacy investigated in a pilot study"],"prefix":"10.3389","volume":"14","author":[{"given":"Kristina","family":"Fuhr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Janouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Drujan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Cyrny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelie","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Kreifelts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Nieratschker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/00029157.2016.1163662","article-title":"Cognitive hypnotherapy for accessing and healing emotional injuries for anxiety disorders","volume":"59","author":"Alladin","year":"2016","journal-title":"Am. J. Clin. Hyp."},{"volume-title":"Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5","year":"2013","key":"B2"},{"key":"B3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.cbpra.2011.04.006","article-title":"Imagery rescripting for personality disorders","volume":"18","author":"Arntz","year":"2011","journal-title":"Cogn. Behav. Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5127\/jep.024211","article-title":"Imagery rescripting as a therapeutic technique: Review of clinical trials, basic studies, and research agenda","volume":"3","author":"Arntz","year":"2012","journal-title":"J. Exp. Psychopathol."},{"volume-title":"Panic and Agoraphobia Scale (PAS).","year":"1999","author":"Bandelow","key":"B5"},{"key":"B6","unstructured":"BandelowB.\n            WiltinkJ.\n            AlpersG. W.\n            BeneckeC.\n            DeckertJ.\n            Eckhardt-HennA.\n          Deutsche S3-Leitlinie Behandlung von Angstst\u00f6rungen2014"},{"key":"B7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-3-319-53889-1_8","article-title":"Anxiety and epigenetics","volume":"978","author":"Bartlett","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/gbb.12090","article-title":"The interaction of early life experiences with COMT val158met affects anxiety sensitivity","volume":"12","author":"Baumann","year":"2013","journal-title":"Genes Brain Behav."},{"key":"B9","first-page":"56","article-title":"Hypnotic psychotherapy for panic disorder: an empirical comparison with cognitive psychotherapy. Evidence-based psychiatric care","volume":"5","author":"Calzeroni","year":"2019","journal-title":"J. Ital. Soc. Psychiat."},{"key":"B10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/00031305.1981.10479327","article-title":"Rank transformations as a bridge between parametric and nonparametric statistics","volume":"35","author":"Conover","year":"1981","journal-title":"Am. Stat."},{"key":"B11","first-page":"69","article-title":"The use of hypnotic regression with panic disorder: a case report","volume":"16","author":"Delmonte","year":"1995","journal-title":"Aust. J. Clin. Hypnother. Hyp."},{"key":"B12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1017\/S146114570400416X","article-title":"Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women","volume":"7","author":"Domschke","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/mp.2011.132","article-title":"Therapygenetics: the 5HTTLPR and response to psychological therapy","volume":"17","author":"Eley","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.2174\/138161212803530907","article-title":"The role of life events and HPA axis in anxiety disorders: a review","volume":"18","author":"Faravelli","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res. Meth."},{"key":"B16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jad.2021.02.069","article-title":"Efficacy of hypnotherapy compared to cognitive behavioural therapy for mild to moderate depression \u2013 Results of a randomized controlled rater-blind trial","volume":"286","author":"Fuhr","year":"2021","journal-title":"J. Affect. Disord."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.4135\/9781412983419","volume-title":"ANOVA: Repeated Measures. (Sage University Paper series on Quantitative Applications in the Social Sciences, series no.07-084)","author":"Girden","year":"1992"},{"key":"B18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.brat.2013.09.009","article-title":"Long-term stability of cognitive behavioral therapy effects for panic disorder with agoraphobia: a two-year follow-up study","volume":"51","author":"Gloster","year":"2013","journal-title":"Behav. Res. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/00207140601177889","article-title":"Cognitive-behavioral hypnotherapy in the treatment of irritable-bowel-syndrome-induced agoraphobia","volume":"55","author":"Golden","year":"2007","journal-title":"Int. J. Clin. Exp. Hyp."},{"key":"B20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/00029157.2011.650333","article-title":"Cognitive hypnotherapy for anxiety disorders","volume":"54","author":"Golden","year":"2012","journal-title":"Am. J. Clin. Hyp."},{"key":"B21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.euroneuro.2005.04.006","article-title":"The epidemiology of panic disorder and agoraphobia in Europe","volume":"15","author":"Goodwin","year":"2005","journal-title":"Eur. Neuropsychopharm."},{"key":"B22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.31887\/DCNS.2017.19.2\/kdomschke","article-title":"Genetics of generalized anxiety disorder and related traits","volume":"19","author":"Gottschalk","year":"2017","journal-title":"Dialog. Clin. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/00207147108407147","article-title":"Agoraphobia: a case study in hypnotherapy","volume":"19","author":"Gruenewald","year":"1971","journal-title":"Int. J. Clin. Exp. Hyp."},{"key":"B24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jphysparis.2016.10.001","article-title":"Functional changes in brain activity after hypnosis in patients with dental phobia","volume":"109","author":"Halsband","year":"2015","journal-title":"J. Physiol. Paris"},{"key":"B25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0006-3223(01)01322-1","article-title":"Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22","volume":"51","author":"Hamilton","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"B26","first-page":"92","article-title":"Hypnotherapy for agoraphobia: a case study","volume":"38","author":"Harris","year":"1991","journal-title":"Int. J. Psychosom."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1176\/appi.ajp.158.10.1568","article-title":"A review and meta-analysis of the genetic epidemiology of anxiety disorders","volume":"158","author":"Hettema","year":"2001","journal-title":"Am. J. Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/NMD.0000000000000419","article-title":"Agoraphobia with and without panic disorder: a 20-year follow-up of integrated exposure and psychodynamic therapy","volume":"204","author":"Hoffart","year":"2016","journal-title":"J. Nerv. Ment. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.eurpsy.2007.02.002","article-title":"Role of the COMT gene Val158Met polymorphism in mental disorders: a review","volume":"22","author":"Hos\u00e1k","year":"2007","journal-title":"Eur. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/mp.2015.138","article-title":"Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways","volume":"21","author":"Howe","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00115-013-3961-y","article-title":"Psychische St\u00f6rungen in der Allgemeinbev\u00f6lkerung","volume":"85","author":"Jacobi","year":"2014","journal-title":"Nervenarzt"},{"key":"B32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.31887\/DCNS.2015.17.3\/akaczkurkin","article-title":"Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence","volume":"17","author":"Kaczkurkin","year":"2015","journal-title":"Dialog. Clin. Neurosc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int. J. Meth. Psych. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.janxdis.2008.01.008","article-title":"Is internet-based CBT for panic disorder and agoraphobia as effective as face-to-face CBT?","volume":"22","author":"Kiropoulos","year":"2008","journal-title":"J. Anxiety Disord."},{"key":"B36","first-page":"235","article-title":"Counteracting resistance in agoraphobia using hypnosis","volume":"28","author":"Kraft","year":"2011","journal-title":"Contemp. Hyp. Integ. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1076\/iceh.52.1.47.23922","article-title":"Hypnotic susceptibility: multidimensional relationships with Cloninger's Tridimensional Personality Questionnaire, COMT polymorphisms, absorption, and attentional characteristics","volume":"52","author":"Lichtenberg","year":"2004","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"B38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/1096-8628(20001204)96:6<771::aid-ajmg14>3.0.co;2-t","article-title":"Exploratory association study between catechol-O-methyltransferase (COMT) high\/low enzyme activity polymorphism and hypnotizability","volume":"96","author":"Lichtenberg","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cpr.2015.08.004","article-title":"Response rates for CBT for anxiety disorders: need for standardized criteria","volume":"42","author":"Loerinc","year":"2015","journal-title":"Clin. Psychol. Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neubiorev.2016.04.005","article-title":"Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application","volume":"66","author":"Lueken","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0167-9473(93)E0045-6","article-title":"A comparative study of some rank tests for interaction","volume":"19","author":"Mansouri","year":"1995","journal-title":"Comput. Stat. Data Anal."},{"key":"B42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ajmg.b.30316","article-title":"Evidence for monozygotic twin (MZ) discordance in methylation level at two CpG sites in the promoter region of the catechol-O-methyltransferase (COMT) gene","volume":"141","author":"Mill","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jad.2005.05.003","article-title":"A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia","volume":"88","author":"Mitte","year":"2005","journal-title":"J. Affect. Disord."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-022-01802-7","article-title":"DNA-methylation dynamics across short-term, exposure-containing CBT in patients with panic disorder","volume":"12","author":"Moser","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B45","unstructured":"Generalised Anxiety Disorder and Panic Disorder in Adults: Management Clinical Guideline. NICE2011"},{"key":"B46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00213-010-2151-x","article-title":"Gene\u2013environment interactions: early life stress and risk for depressive and anxiety disorders","volume":"214","author":"Nugent","year":"2011","journal-title":"Psychopharmacology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1192\/bjp.2021.148","article-title":"Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials","volume":"221","author":"Papola","year":"2022","journal-title":"Br. J. Psychiat."},{"key":"B48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/00207144.2021.1877549","article-title":"Clinical hypnosis as an adjunct to cognitive behavior therapy: an updated meta-analysis","volume":"69","author":"Ramondo","year":"2021","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-54577-1","volume-title":"Hypnose in Psychotherapie, Psychosomatik und Medizin","author":"Revenstorf","year":"2015"},{"key":"B50","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ajmg.b.32650","article-title":"DNA methylation of FKBP5 and response to exposure-based psychological therapy","volume":"180","author":"Roberts","year":"2019","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/da.22430","article-title":"HPA axis related genes and response to psychological therapies: genetics and epigenetics","volume":"32","author":"Roberts","year":"2015","journal-title":"Depress. Anxiety"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1038\/tp.2014.83","article-title":"Serotonin tranporter methylation and response to cognitive behaviour therapy in children with anxiety disorders","volume":"4","author":"Roberts","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/00207144.2014.931177","article-title":"Carriers of the COMT Met\/Met allele have higher degrees of hypnotizability, provided that they have good attentional control: a case of gene\u2013trait interaction","volume":"62","author":"Rominger","year":"2014","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"B54","doi-asserted-by":"publisher","first-page":"101830","DOI":"10.1016\/j.cpr.2020.101830","article-title":"The applied implications of epigenetics in anxiety, affective and stress-related disorders-A review and synthesis on psychosocial stress, psychotherapy and prevention","volume":"77","author":"Schiele","year":"2020","journal-title":"Clin. Psychol. Rev."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/texcom\/tgaa050","article-title":"Feel safe and money is less important! hypnotic suggestions of safety decrease brain responses to monetary rewards in a risk game","author":"Schmidt","year":"2020","journal-title":"Cereb. Cortex Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-12-115","article-title":"Association of COMT genotypes with S-COMT promoter methylation in growth-discordant monozygotic twins and healthy adults","volume":"12","author":"Schreiner","year":"2011","journal-title":"BMC Med. Genet."},{"key":"B57","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiat."},{"key":"B58","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/da.22046","article-title":"Tranceformations: hypnosis in brain and body","volume":"30","author":"Spiegel","year":"2013","journal-title":"Depress. Anxiety"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/sj.npp.1300787","article-title":"COMT polymorphisms and anxiety-related personality traits","volume":"30","author":"Stein","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/00207144.2018.1396120","article-title":"COMT genotype and sensory and sensorimotor gating in high and low hypnotizable subjects","volume":"66","author":"Storozheva","year":"2018","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"B61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11920-020-1139-4","article-title":"Imagery rescripting for anxiety disorders and obsessive-compulsive disorder: recent advances and future directions","volume":"22","author":"Strachan","year":"2020","journal-title":"Curr. Psychiat. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-8794-7-5","article-title":"Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator","volume":"7","author":"Swift-Scanlan","year":"2014","journal-title":"BMC Med. Genom."},{"key":"B63","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/00207141003760827","article-title":"Association between hypnotizability and the catechol-O-methyltransferase (COMT) polymorphism","volume":"58","author":"Szekely","year":"2010","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"B64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ajmg.b.32556","article-title":"Association between COMT Val158Met and psychiatric disorders: a comprehensive meta-analysis","volume":"177","author":"Taylor","year":"2018","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.euroneuro.2019.09.011","article-title":"Differential COMT DNA methylation in patients with borderline personality disorder: genotype matters","volume":"29","author":"Thomas","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/00207144.2019.1613863","article-title":"The efficacy of hypnosis as a treatment for anxiety: a meta-analysis","volume":"67","author":"Valentine","year":"2019","journal-title":"Int. J. Clin. Exp. Hyp."},{"key":"B67","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/01454455970212003","article-title":"Does preference for type of treatment matter? A study of exposure in vivo with or without hypnosis in the treatment of panic disorder with agoraphobia","volume":"21","author":"Van Dyck","year":"1997","journal-title":"Behav. Modif."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1017\/S0033291712000876","article-title":"A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia","volume":"42","author":"Vos","year":"2012","journal-title":"Psychol. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur. Neuropsychopharm."},{"key":"B70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-08-010054-8.50006-X","article-title":"The systematic desensitization treatment of neuroses","volume-title":"Experiments in Behaviour Therapy: Readings in Modern Methods of Treatment of Mental Disorders Derived from Learning Theory","author":"Wolpe","year":"1964"},{"key":"B71","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fpsyt.2018.00533","article-title":"Psychotherapeutic group intervention for traumatized male refugees using imaginative stabilization techniques\u2014a pilot study in a german reception center","volume":"9","author":"Zehetmair","year":"2018","journal-title":"Front. Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-019-0648-6","article-title":"The DNA methylome in panic disorder: a case-control and longitudinal psychotherapy-epigenetic study","volume":"9","author":"Ziegler","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.1038\/tp.2016.41","article-title":"MAOA gene hypomethylation in panic disorder\u2014reversibility of an epigenetic risk pattern by psychotherapy","volume":"6","author":"Ziegler","year":"2016","journal-title":"Transl. Psychiatry."},{"key":"B74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/00220973.1993.9943832","article-title":"Relative power of the Wilcoxon test, the Friedman test, and repeated-measures ANOVA on ranks","volume":"62","author":"Zimmerman","year":"1993","journal-title":"J. Exp. Educ."}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2023.1213792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T15:54:58Z","timestamp":1691682898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2023.1213792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":74,"alternative-id":["10.3389\/fpsyg.2023.1213792"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2023.1213792","relation":{},"ISSN":["1664-1078"],"issn-type":[{"type":"electronic","value":"1664-1078"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"article-number":"1213792"}}